Gender-based radiation exposure and clinical outcomes in peripheral endovascular intervention for limb ischemia: A prospective study

Table 2 Patient gender characteristics in peripheral intervention

	Male, n = 71	Female, n = 76	P value
Age	64.4 ± 11.6	65.8 ± 13.4	0.49
Weight (kg)	80.3 ± 16.2	73.6 ± 16.8	0.016
Height (cm)	169.7 ± 14.8	158.7 ± 7.9	< 0.001
Body mass index (kg/m2)	27.5 ±5.3	29.3 ± 6.5	0.069
Body surface area (m2)	1.9 ± 0.2	1.8 ± 0.2	< 0.001
Follow-up (month)	4.0 ± 3.5	4.0 ± 3.6	0.84
Diabetes	42 (59)	58 (76)	0.026
Hypertension	50 (70)	62 (82)	0.11
Hyperlipidemia	32 (45)	40 (53)	0.36
Past history of coronary artery disease	18 (25)	30 (39)	0.068
History of MI/PCI	16 (23)	25 (33)	0.16
Atrial fibrillation/flutter	4 (6)	8 (11)	0.28
History of chronic kidney disease/end stage renal disease on hemodialysis	1 (1)	5 (7)	0.11
History of peripheral intervention	23 (32)	19 (25)	0.32
History of vascular surgery	2 (3)	2 (3)	0.94
History of acute limb ischemia/critical limb ischemia	11 (15)	16 (21)	0.38
Current/former smoker	45 (63)	25 (33)	< 0.001
History of amputation	8 (11)	13 (17)	0.31
Intermittent claudication	7 (10)	10 (13)	0.53
Critical limb ischemia	37 (52)	39 (51)	0.92
Acute limb ischemia	11 (15)	19 (25)	0.15
Lower extremity edema/deep venous thrombosis/May Thurner/chronic total occlusion vein	14 (20)	7 (9)	0.069
Venous stenosis	0 (0)	1 (1)	0.33
Re-look angiography	5 (7)	5 (7)	0.91
Peripheral aneurysm	2 (3)	0 (0)	0.14
Suprainguinal	20 (28)	21 (28)	0.94
Infrainguinal	42 (59)	52 (68)	0.24
Infrapopliteal	29 (41)	37 (49)	0.34
Intervention	71 (100)	75 (99)	0.33
Chronic total occlusion intervention	23 (32)	31 (41)	0.29
Dissection/perforation	6 (8)	12 (16)	0.17
Femoral access	60 (85)	69 (91)	0.25
Pedal	11 (15)	5 (7)	0.083
Retrograde	68 (96)	73 (96)	0.93
Antegrade	0 (0)	1 (1)	0.33
Brachial/radial	12 (17)	3 (4)	0.010
Venous intervention	12 (17)	7 (9)	0.16
Tasc A	5 (7)	8 (11)	0.46
Tasc B	27 (38)	21 (28)	0.18
Tasc C	19 (27)	33 (43)	0.035
Tasc D	6 (8)	6 (8)	0.90
Ruth grade I	7 (10)	12 (16)	0.28
Ruth grade II	20 (28)	32 (42)	0.077
Ruth grade III	27 (38)	16 (21)	0.024
Ruth grade IV	1 (1)	0 (0)	0.30
Fontaine I	0	0
Fontaine II	7 (10)	17 (22)	0.040
Fontaine III	10 (14)	23 (30)	0.019
Fontaine IV	28 (39)	14 (18)	0.005
Staged intervention	9 (13)	8 (11)	0.68

Data were showed as mean ± SD or n (%). DAP: Dose area product; MI/PCI: Myocardial infarction/percutaneous coronary intervention; TASC: Transatlantic intersociety consensus.